Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
51.90
-0.30 (-0.57%)
Jul 31, 2026, 5:30 PM CET

Basilea Pharmaceutica AG Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Investments
----95
Cash & Short-Term Investments
----95
Cash Growth
-----5.96%
Accounts Receivable
13.498.8827.8933.1524.95
Other Receivables
49.7949.3130.2628.5539.5
Total Trade Receivables
63.2858.1858.1561.764.45
Inventory
21.5631.6126.4124.2422.78
Other Current Assets
7.110.417.654.765.14
Total Current Assets
251.73220.91152.15175.36241.07
Net Property, Plant & Equipment
18.1518.9820.5521.572.92
Other Intangible Assets
0.370.370.550.580.63
Other Long-Term Assets
11.7517.50.0423.342.65
Total Assets
282257.76173.29220.85247.27

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
15.0611.495.850.1910.62
Accrued Expenses
30.5230.392333.9738.16
Current Portion of Long-Term Debt
--15.4537.47123.51
Current Portion of Leases
2.062.062.061.990.9
Unearned Revenue
1.571.621.231.231.23
Total Current Liabilities
49.2245.5647.5974.85174.41
Long-Term Debt
75.4495.9195.46131.3694.54
Long-Term Leases
11.7213.715.6416.320.01
Other Long-Term Liabilities
17.6921.624.6119.0336.91
Total Long-Term Liabilities
104.84131.21135.7166.71131.47
Total Liabilities
154.06176.77183.29241.56305.87

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
13.3213.1713.113.0912.99
Treasury Stock
-51.28-51.7-54.01-56.07-56.56
Additional Paid-in Capital
1,0521,0481,0421,0371,030
Accumulated Other Comprehensive Income
-3.9-4.74-10.21-3.78-21.62
Retained Earnings
-882.57-923.29-1,001-1,011-1,023
Shareholders' Equity
127.9481-10-20.72-58.61
Total Liabilities & Equity
282257.76173.29220.85247.27

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
89.22111.67128.61187.14218.96
Net Cash (Debt)
-89.22-111.67-128.61-187.14-123.96
Net Cash Growth
-----
Net Cash Per Share
-6.52-8.06-10.59-15.67-10.61
Book Value
127.9481-10-20.72-58.61
Book Value Per Share
9.355.85-0.82-1.73-5.02
Tangible Book Value
127.5780.63-10.55-21.29-59.24
Tangible Book Value Per Share
9.325.82-0.87-1.78-5.07